{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T07:07:45Z","timestamp":1782544065259,"version":"3.54.5"},"reference-count":82,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":9,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFF1200404"],"award-info":[{"award-number":["2021YFF1200404"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1201200"],"award-info":[{"award-number":["2021YFA1201200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1967217"],"award-info":[{"award-number":["U1967217"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Center of Technology Innovation for Biopharmaceuticals","award":["NCTIB2022HS02010"],"award-info":[{"award-number":["NCTIB2022HS02010"]}]},{"name":"Shanghai Artificial Intelligence Lab","award":["P22KN00272"],"award-info":[{"award-number":["P22KN00272"]}]},{"name":"National Independent Innovation Demonstration Zone Shanghai Zhangjiang Major Projects","award":["ZJZX2020014"],"award-info":[{"award-number":["ZJZX2020014"]}]},{"name":"Starry Night Science Fund of Zhejiang University Shanghai Institute for Advanced Study","award":["SN-ZJU-SIAS-003"],"award-info":[{"award-number":["SN-ZJU-SIAS-003"]}]},{"name":"Zhejiang University Global Partnership Fund","award":["188170+194452409\/004"],"award-info":[{"award-number":["188170+194452409\/004"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Neoantigen-based immunotherapy has emerged as a promising approach for cancer treatment. One key strategy in neoantigen-based vaccine design is to alter known neoantigens into enhanced mimotopes that elicit more robust immune responses. However, screening mimotopes presents challenges in both diversity and precision. While machine learning (ML) models facilitate high-throughput screening of immunogenic candidates, they struggle to distinguish mimotopes from original neoantigens (i.e. identify mimotopes with higher binding affinities, rather than solely distinguish between binding and nonbinding peptides). In contrast, alchemical methods such as free energy perturbation (FEP) provide quantitative binding free-energy differences between mimotopes and neoantigens but are computationally intensive. To leverage the strengths of both approaches, we propose an FEP-assisted ML (FEPaML) strategy that employs Bayesian optimization to iteratively refine knowledge-based predictions with physics-based evaluations, thereby progressively achieving locally optimized, precise, and robust outcomes. Our FEPaML strategy is then applied to screen mimotopes for several representative neoantigens. It has demonstrated excellent predictive precisions (exceeding 0.9) with a relatively small number of FEP samplings, significantly outperforming existing ML models.<\/jats:p>","DOI":"10.1093\/bib\/bbaf254","type":"journal-article","created":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T07:22:28Z","timestamp":1751872948000},"source":"Crossref","is-referenced-by-count":5,"title":["A free energy perturbation-assisted machine learning strategy for mimotope screening in neoantigen-based vaccine design"],"prefix":"10.1093","volume":"26","author":[{"given":"Qinglu","family":"Zhong","sequence":"first","affiliation":[{"name":"College of Life Sciences, College of Physics, Institute of Quantitative Biology, Zhejiang University , 866 Yuhangtang Road, Hangzhou 310058 ,","place":["China"]},{"name":"Shanghai Institute for Advanced Study, Zhejiang University , 799 Dangui Road, Shanghai 201203 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C","family":"Chan","sequence":"additional","affiliation":[{"name":"College of Life Sciences, College of Physics, Institute of Quantitative Biology, Zhejiang University , 866 Yuhangtang Road, Hangzhou 310058 ,","place":["China"]},{"name":"Shanghai Institute for Advanced Study, Zhejiang University , 799 Dangui Road, Shanghai 201203 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Fu","sequence":"additional","affiliation":[{"name":"College of Life Sciences, College of Physics, Institute of Quantitative Biology, Zhejiang University , 866 Yuhangtang Road, Hangzhou 310058 ,","place":["China"]},{"name":"Shanghai Institute for Advanced Study, Zhejiang University , 799 Dangui Road, Shanghai 201203 ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruhong","family":"Zhou","sequence":"additional","affiliation":[{"name":"College of Life Sciences, College of Physics, Institute of Quantitative Biology, Zhejiang University , 866 Yuhangtang Road, Hangzhou 310058 ,","place":["China"]},{"name":"Shanghai Institute for Advanced Study, Zhejiang University , 799 Dangui Road, Shanghai 201203 ,","place":["China"]},{"name":"Zhejiang Key Laboratory of Cell and Molecular Intelligent Design and Development, Zhejiang University , 866 Yuhangtang Road, Hangzhou 310058 ,","place":["China"]},{"name":"Department of Chemistry, Columbia University , New York, NY 10027 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"2025070923381386700_ref1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"2025070923381386700_ref2","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s13045-019-0787-5","article-title":"Tumor neoantigens: from basic research to clinical applications","volume":"12","author":"Jiang","year":"2019","journal-title":"J Hematol Oncol J Hematol Oncol"},{"key":"2025070923381386700_ref3","doi-asserted-by":"publisher","first-page":"833017","DOI":"10.3389\/fimmu.2022.833017","article-title":"T cell recognition of tumor Neoantigens and insights into T cell immunotherapy","volume":"13","author":"Sim","year":"2022","journal-title":"Front Immunol"},{"key":"2025070923381386700_ref4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2025070923381386700_ref5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev-cancerbio-060820-111701","article-title":"Personal Neoantigen vaccines for the treatment of cancer","volume":"5","author":"Shetty","year":"2021","journal-title":"Annu Rev Cancer Biol"},{"key":"2025070923381386700_ref6","doi-asserted-by":"publisher","first-page":"1105420","DOI":"10.3389\/fimmu.2023.1105420","article-title":"Designing neoantigen cancer vaccines, trials, and outcomes","volume":"14","author":"Biswas","year":"2023","journal-title":"Front Immunol"},{"key":"2025070923381386700_ref7","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"key":"2025070923381386700_ref8","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41591-020-01206-4","article-title":"Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma","volume":"27","author":"Hu","year":"2021","journal-title":"Nat Med"},{"key":"2025070923381386700_ref9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/s41586-018-0792-9","article-title":"Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial","volume":"565","author":"Keskin","year":"2019","journal-title":"Nature"},{"key":"2025070923381386700_ref10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41586-018-0810-y","article-title":"Actively personalized vaccination trial for newly diagnosed glioblastoma","volume":"565","author":"Hilf","year":"2019","journal-title":"Nature"},{"key":"2025070923381386700_ref11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/s41577-023-00937-y","article-title":"Challenges in developing personalized neoantigen cancer vaccines","volume":"24","author":"Katsikis","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"2025070923381386700_ref12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1159\/000448756","article-title":"On peptides and altered peptide ligands: from origin, mode of action and design to clinical application (immunotherapy)","volume":"170","author":"Candia","year":"2016","journal-title":"Int Arch Allergy Immunol"},{"key":"2025070923381386700_ref13","doi-asserted-by":"publisher","first-page":"101395","DOI":"10.1016\/j.smim.2020.101395","article-title":"Peptide mimotopes alter T cell function in cancer and autoimmunity","volume":"47","author":"Slansky","year":"2020","journal-title":"Semin Immunol"},{"key":"2025070923381386700_ref14","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.immuni.2009.09.025","article-title":"T cell Allorecognition via molecular mimicry","volume":"31","author":"Macdonald","year":"2009","journal-title":"Immunity"},{"key":"2025070923381386700_ref15","doi-asserted-by":"crossref","first-page":"2103023","DOI":"10.1002\/advs.202103023","article-title":"Position-scanning peptide libraries as particle Immunogens for improving CD8 + T-cell responses","volume":"8","author":"He","year":"2021","journal-title":"Adv Sci"},{"key":"2025070923381386700_ref16","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.molimm.2021.05.001","article-title":"Tumor rejection properties of gp100209-specific T cells correlate with T cell receptor binding affinity towards the wild type rather than anchor-modified antigen","volume":"135","author":"Alonso","year":"2021","journal-title":"Mol Immunol"},{"key":"2025070923381386700_ref17","doi-asserted-by":"publisher","first-page":"e2018125118","DOI":"10.1073\/pnas.2018125118","article-title":"Structurally silent peptide anchor modifications allosterically modulate T cell recognition in a receptor-dependent manner","volume":"118","author":"Smith","year":"2021","journal-title":"Proc Natl Acad Sci"},{"key":"2025070923381386700_ref18","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1158\/1078-0432.CCR-10-3272","article-title":"Intra\u2013lymph node prime-boost vaccination against Melan a and Tyrosinase for the treatment of metastatic melanoma: results of a phase 1 clinical trial","volume":"17","author":"Ribas","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2025070923381386700_ref19","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1479-5876-12-97","article-title":"MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a phase I trial","volume":"12","author":"Romano","year":"2014","journal-title":"J Transl Med"},{"key":"2025070923381386700_ref20","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.1158\/1078-0432.CCR-12-1516","article-title":"Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I\u2013modified peptides","volume":"18","author":"Filipazzi","year":"2012","journal-title":"Clin Cancer Res"},{"key":"2025070923381386700_ref21","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1056\/NEJMoa1012863","article-title":"gp100 peptide vaccine and Interleukin-2 in patients with advanced melanoma","volume":"364","author":"Schwartzentruber","year":"2011","journal-title":"N Engl J Med"},{"key":"2025070923381386700_ref22","doi-asserted-by":"publisher","first-page":"5097","DOI":"10.4049\/jimmunol.1300467","article-title":"Structure-based Design of Altered MHC class II\u2013restricted peptide ligands with heterogeneous immunogenicity","volume":"191","author":"Chen","year":"2013","journal-title":"J Immunol"},{"key":"2025070923381386700_ref23","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1126\/science.aao4572","article-title":"Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy","volume":"359","author":"Chowell","year":"2018","journal-title":"Science"},{"key":"2025070923381386700_ref24","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/nar\/29.1.210","article-title":"IMGT\/HLA database\u2014a sequence database for the human major histocompatibility complex","volume":"29","author":"Robinson","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"2025070923381386700_ref25","doi-asserted-by":"publisher","first-page":"107882","DOI":"10.1016\/j.celrep.2020.107882","article-title":"High frequency of shared Clonotypes in human T cell receptor repertoires","volume":"32","author":"Soto","year":"2020","journal-title":"Cell Rep"},{"key":"2025070923381386700_ref26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41571-023-00830-6","article-title":"Computational immunogenomic approaches to predict response to cancer immunotherapies","volume":"21","author":"Addala","year":"2024","journal-title":"Nat Rev Clin Oncol"},{"key":"2025070923381386700_ref27","doi-asserted-by":"publisher","first-page":"W449","DOI":"10.1093\/nar\/gkaa379","article-title":"NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data","volume":"48","author":"Reynisson","year":"2020","journal-title":"Nucleic Acids Res"},{"key":"2025070923381386700_ref28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cels.2020.06.010","article-title":"MHCflurry 2.0: improved pan-allele prediction of MHC class I-presented peptides by incorporating antigen processing","volume":"11","author":"O\u2019Donnell","year":"2020","journal-title":"Cell Syst"},{"key":"2025070923381386700_ref29","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s42256-022-00459-7","article-title":"A transformer-based model to predict peptide\u2013HLA class I binding and optimize mutated peptides for vaccine design","volume":"4","author":"Chu","year":"2022","journal-title":"Nat Mach Intell"},{"key":"2025070923381386700_ref30","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41573-021-00387-y","article-title":"Identification of neoantigens for individualized therapeutic cancer vaccines","volume":"21","author":"Lang","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"2025070923381386700_ref31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/S0959-440X(02)00308-1","article-title":"Molecular dynamics simulations","volume":"12","author":"Hansson","year":"2002","journal-title":"Curr Opin Struct Biol"},{"key":"2025070923381386700_ref32","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/s42004-023-01019-9","article-title":"The maximal and current accuracy of rigorous protein-ligand binding free energy calculations","volume":"6","author":"Ross","year":"2023","journal-title":"Commun Chem"},{"key":"2025070923381386700_ref33","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1021\/acsmedchemlett.2c00541","article-title":"Recent advances in alchemical binding free energy calculations for drug discovery","volume":"14","author":"Muegge","year":"2023","journal-title":"ACS Med Chem Lett"},{"key":"2025070923381386700_ref34","doi-asserted-by":"publisher","first-page":"e2214430120","DOI":"10.1073\/pnas.2214430120","article-title":"A mutagenesis study of autoantigen optimization for potential T1D vaccine design","volume":"120","author":"Song","year":"2023","journal-title":"Proc Natl Acad Sci"},{"key":"2025070923381386700_ref35","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/nature14541","article-title":"Probabilistic machine learning and artificial intelligence","volume":"521","author":"Ghahramani","year":"2015","journal-title":"Nature"},{"key":"2025070923381386700_ref36","article-title":"Are we forgetting about compositional optimisers in Bayesian optimisation?","volume-title":"Journal of Machine Learning Research","author":"Grosnit"},{"key":"2025070923381386700_ref37","volume-title":"Attention Is All You Need","author":"Vaswani","year":"2023"},{"key":"2025070923381386700_ref38","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1126\/science.286.5444.1461","article-title":"A brief guide to Bayes theorem","volume":"286","author":"Malakoff","year":"1999","journal-title":"Science"},{"key":"2025070923381386700_ref39","article-title":"BERT: pre-training of deep bidirectional transformers for language understanding","author":"Devlin","year":"2019"},{"key":"2025070923381386700_ref40","doi-asserted-by":"publisher","DOI":"10.1002\/cpbi.3","article-title":"Comparative protein structure Modeling using MODELLER","volume":"54","author":"Webb","year":"2016","journal-title":"Curr Protoc Bioinformatics"},{"key":"2025070923381386700_ref41","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J Chem Phys"},{"key":"2025070923381386700_ref42","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J Comput Chem"},{"key":"2025070923381386700_ref43","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1021\/ct300400x","article-title":"Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone \u03d5, \u03c8 and side-chain \u03c7 1 and \u03c7 2 dihedral angles","volume":"8","author":"Best","year":"2012","journal-title":"J Chem Theory Comput"},{"key":"2025070923381386700_ref44","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J Chem Phys"},{"key":"2025070923381386700_ref45","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1002\/(SICI)1096-987X(199709)18:12&lt;1463::AID-JCC4&gt;3.0.CO;2-H","article-title":"LINCS: a linear constraint solver for molecular simulations","volume":"18","author":"Hess","year":"1997","journal-title":"J Comput Chem"},{"key":"2025070923381386700_ref46","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1080\/00268978400101201","article-title":"A molecular dynamics method for simulations in the canonical ensemble","volume":"52","author":"Nos\u00e9","year":"1984","journal-title":"Mol Phys"},{"key":"2025070923381386700_ref47","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1103\/PhysRevA.31.1695","article-title":"Canonical dynamics: equilibrium phase-space distributions","volume":"31","author":"Hoover","year":"1985","journal-title":"Phys Rev A"},{"key":"2025070923381386700_ref48","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.1063\/1.328693","article-title":"Polymorphic transitions in single crystals: a new molecular dynamics method","volume":"52","author":"Parrinello","year":"1981","journal-title":"J Appl Phys"},{"key":"2025070923381386700_ref49","doi-asserted-by":"publisher","first-page":"5151","DOI":"10.1021\/acs.jpcb.2c00962","article-title":"Binding affinity calculations of gluten peptides to HLA risk modifiers: DQ2.5 versus DQ7.5","volume":"126","author":"Song","year":"2022","journal-title":"J Phys Chem B"},{"key":"2025070923381386700_ref50","doi-asserted-by":"publisher","first-page":"127199","DOI":"10.1016\/j.ijbiomac.2023.127199","article-title":"The rigidity of a structural bridge on HLA-I binding groove explains its differential outcome in cancer immune response","volume":"253","author":"Zhou","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"2025070923381386700_ref51","doi-asserted-by":"publisher","first-page":"10459","DOI":"10.1021\/acs.jpcb.3c04370","article-title":"Standard binding free-energy calculations: how far are we from automation?","volume":"127","author":"Fu","year":"2023","journal-title":"J Phys Chem B"},{"key":"2025070923381386700_ref52","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1063\/1.1740409","article-title":"High-temperature equation of state by a perturbation method","volume":"22","author":"Zwanzig","year":"1954","journal-title":"I Nonpolar Gases J Chem Phys"},{"key":"2025070923381386700_ref53","doi-asserted-by":"publisher","first-page":"124105","DOI":"10.1063\/1.2978177","article-title":"Statistically optimal analysis of samples from multiple equilibrium states","volume":"129","author":"Shirts","year":"2008","journal-title":"J Chem Phys"},{"key":"2025070923381386700_ref54","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/jcc.23804","article-title":"Pmx: automated protein structure and topology generation for alchemical perturbations","volume":"36","author":"Gapsys","year":"2015","journal-title":"J Comput Chem"},{"key":"2025070923381386700_ref55","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/0009-2614(94)00397-1","article-title":"Avoiding singularities and numerical instabilities in free energy calculations based on molecular simulations","volume":"222","author":"Beutler","year":"1994","journal-title":"Chem Phys Lett"},{"key":"2025070923381386700_ref56","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10822-015-9840-9","article-title":"Guidelines for the analysis of free energy calculations","volume":"29","author":"Klimovich","year":"2015","journal-title":"J Comput Aided Mol Des"},{"key":"2025070923381386700_ref57","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","article-title":"Understanding the complexity of p53 in a new era of tumor suppression","volume":"42","author":"Liu","year":"2024","journal-title":"Cancer Cell"},{"key":"2025070923381386700_ref58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrclinonc.2017.151","article-title":"Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others","volume":"15","author":"Sabapathy","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"2025070923381386700_ref59","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","article-title":"Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients","volume":"23","author":"Zehir","year":"2017","journal-title":"Nat Med"},{"key":"2025070923381386700_ref60","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2217\/pgs-2019-0184","article-title":"Shared neoantigens: ideal targets for off-the-shelf cancer immunotherapy","volume":"21","author":"Zhao","year":"2020","journal-title":"Pharmacogenomics"},{"key":"2025070923381386700_ref61","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1158\/2326-6066.CIR-18-0686","article-title":"Immunologic recognition of a shared p53 mutated Neoantigen in a patient with metastatic colorectal cancer","volume":"7","author":"Lo","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"2025070923381386700_ref62","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1172\/JCI123791","article-title":"Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers","volume":"129","author":"Malekzadeh","year":"2019","journal-title":"J Clin Invest"},{"key":"2025070923381386700_ref63","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1093\/bioinformatics\/btv123","article-title":"Automated benchmarking of peptide-MHC class I binding predictions","volume":"31","author":"Trolle","year":"2015","journal-title":"Bioinformatics"},{"key":"2025070923381386700_ref64","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/978-3-642-04747-3_26","article-title":"Precision and recall for regression","volume":"5808","author":"Torgo","year":"2009","journal-title":"Discov Sci"},{"key":"2025070923381386700_ref65","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.1002\/ijc.34453","article-title":"A phase 1 trial of NY-ESO -1-specific TCR -engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma","volume":"152","author":"Ishihara","year":"2023","journal-title":"Int J Cancer"},{"key":"2025070923381386700_ref66","doi-asserted-by":"publisher","first-page":"23438","DOI":"10.1074\/jbc.M314066200","article-title":"Functional and structural characteristics of NY-ESO-1-related HLA A2-restricted epitopes and the Design of a Novel Immunogenic Analogue","volume":"279","author":"Webb","year":"2004","journal-title":"J Biol Chem"},{"key":"2025070923381386700_ref67","doi-asserted-by":"publisher","first-page":"393","DOI":"10.3390\/cancers15020393","article-title":"WT1 trio peptide-based cancer vaccine for rare cancers expressing shared target WT1","volume":"15","author":"Oji","year":"2023","journal-title":"Cancers"},{"key":"2025070923381386700_ref68","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1016\/j.molimm.2010.06.005","article-title":"Structures of native and affinity-enhanced WT1 epitopes bound to HLA-A0201: implications for WT1-based cancer therapeutics","volume":"47","author":"Borbulevych","year":"2010","journal-title":"Mol Immunol"},{"key":"2025070923381386700_ref69","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/d41586-023-02896-9","article-title":"AI can help to speed up drug discovery \u2014 but only if we give it the right data","volume":"621","author":"Mock","year":"2023","journal-title":"Nature"},{"key":"2025070923381386700_ref70","volume-title":"Textbooks Are All You Need","author":"Gunasekar","year":"2023"},{"key":"2025070923381386700_ref71","doi-asserted-by":"publisher","first-page":"e4841","DOI":"10.1002\/pro.4841","article-title":"TEPCAM\u00a0: Prediction of T -cell receptor\u2013epitope binding specificity via interpretable deep learning","volume":"33","author":"Chen","year":"2024","journal-title":"Protein Sci"},{"key":"2025070923381386700_ref72","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1109\/JBHI.2024.3514089","article-title":"GRATCR: epitope-specific T cell receptor sequence generation with data-efficient pre-trained models","volume":"29","author":"Zhou","year":"2025","journal-title":"IEEE J Biomed Health Inform"},{"key":"2025070923381386700_ref73","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s42256-024-00901-y","article-title":"Sliding-attention transformer neural architecture for predicting T cell receptor\u2013antigen\u2013human leucocyte antigen binding","volume":"6","author":"Feng","year":"2024","journal-title":"Nat Mach Intell"},{"key":"2025070923381386700_ref74","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1038\/s42256-024-00913-8","article-title":"Epitope-anchored contrastive transfer learning for paired CD8+ T cell receptor\u2013antigen recognition","volume":"6","author":"Zhang","year":"2024","journal-title":"Nat Mach Intell"},{"key":"2025070923381386700_ref75","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41590-024-02044-z","article-title":"Low-avidity T cells drive endogenous tumor immunity in mice and humans","volume":"26","author":"Singhaviranon","year":"2025","journal-title":"Nat Immunol"},{"key":"2025070923381386700_ref76","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41422-025-01077-9","article-title":"TCR catch bonds nonlinearly control CD8 cooperation to shape T cell specificity","volume":"35","author":"Qin","year":"2025","journal-title":"Cell Res"},{"key":"2025070923381386700_ref77","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1038\/s41467-025-58503-0","article-title":"Uncertainty quantification with graph neural networks for efficient molecular design","volume":"16","author":"Chen","year":"2025","journal-title":"Nat Commun"},{"key":"2025070923381386700_ref78","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1021\/acscentsci.1c00546","article-title":"Evidential deep learning for guided molecular property prediction and discovery","volume":"7","author":"Soleimany","year":"2021","journal-title":"ACS Cent Sci"},{"key":"2025070923381386700_ref79","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","article-title":"Trends in peptide drug discovery","volume":"20","author":"Muttenthaler","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"2025070923381386700_ref80","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1109\/JPROC.2015.2460697","article-title":"Multimodal data fusion: an overview of methods, challenges, and prospects","volume":"103","author":"Lahat","year":"2015","journal-title":"Proc IEEE"},{"key":"2025070923381386700_ref81","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/s42256-023-00633-5","article-title":"Multimodal data fusion for cancer biomarker discovery with deep learning","volume":"5","author":"Steyaert","year":"2023","journal-title":"Nat Mach Intell"},{"key":"2025070923381386700_ref82","article-title":"The fourth paradigm: data-intensive scientific discovery","year":"2009"}],"container-title":["Briefings in Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/26\/4\/bbaf254\/63714365\/bbaf254.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bib\/article-pdf\/26\/4\/bbaf254\/63714365\/bbaf254.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T03:38:20Z","timestamp":1752118700000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bib\/article\/doi\/10.1093\/bib\/bbaf254\/8195921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7,2]]}},"URL":"https:\/\/doi.org\/10.1093\/bib\/bbaf254","relation":{},"ISSN":["1467-5463","1477-4054"],"issn-type":[{"value":"1467-5463","type":"print"},{"value":"1477-4054","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,7]]},"article-number":"bbaf254"}}